CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-07-13). The draft was written by AI, the existence of all 3 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 242 · Search date 2026-07-13 · Methodology v0.6

Magnolia bark extract,
does it really help with Improvement of anxiety, stress, and sleep?

30-Second Summary
?
Evidence Grade ? · Safety caution
Magnolia-phellodendron combination studies cannot determine the effect of magnolia bark or isolated honokiol or magnolol
What the
research shows
The pivotal human studies tested Relora, a combination of magnolia and phellodendron that was also standardized for berberine. Their results cannot be attributed to magnolia, honokiol, or magnolol alone; in the 40-person trial only state anxiety was positive and the remaining endpoints were null, so the grade remains ?.
What the
ads claim
Marketed magnolia-only or high-honokiol products use claims such as 'GABA calming,' 'cortisol control,' and 'restful sleep.' The identified human evidence mainly concerns a magnolia-phellodendron combination, not a sleep trial of isolated honokiol or magnolol.
*

Useful facts when choosing a product

  • The Relora research product combines magnolia bark extract with Phellodendron amurense extract.
  • The standardized ratios of honokiol and magnolol in marketed magnolia products may differ from the research combination.
  • Because sedation is possible, evidence on combination with sleep medicines, anxiolytics, or alcohol is insufficient.
  • Long-term human safety data for the single ingredient are limited.
Gap Measurement · Verdict 242 · ?
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Kalman 2008 gave an ITT population of 40 overweight premenopausal women a magnolia-phellodendron combination at 250 mg three times daily for six weeks. Transient state anxiety decreased, but trait anxiety, depression, cortisol, sleep quality, and sleep latency were not significant versus placebo. Talbott 2013 gave the same combination to 56 moderately stressed adults for four weeks and reported an 18% reduction in salivary cortisol and improvements in stress and mood scales. Neither trial tested magnolia alone, and both had product-related conflicts. A 2017 review likewise concluded that very few clinical trials of magnolia had been published.

02

Why this is classified as ?

Combination-product RCTs show selected signals, but there is no trial of magnolia alone for the stated effects, making ingredient attribution impossible. Under the rule for absence of direct human efficacy literature, the rating is ? and the score is null.

Counterpoint. Stress-related signals from the magnolia-phellodendron combination remain a basis for designing a magnolia-only trial. This assessment does not reject the possibility of an effect from the full combination.

Rejudgment record. Reassessment (cross-check reflected) — The pivotal studies tested Relora, a magnolia-phellodendron combination also standardized for berberine, so results cannot be attributed to magnolia, honokiol, or magnolol alone; in the 40-person trial only state anxiety was positive and the remaining endpoints were null, so the grade remains ?

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Kalman DS et al. 2008Randomized double-blind placebo-controlled pilot trial26Product supplied by Next Pharmaceuticals with product-related author conflictsState and trait anxiety, stress, cortisol, sleep quality, and latencyThe magnolia-phellodendron combination improved state anxiety, but trait anxiety, cortisol, and sleep measures were not significant.Key
Talbott SM et al. 2013Randomized double-blind placebo-controlled trial56Supported by Next PharmaceuticalsSalivary cortisol, perceived stress, and POMSThe magnolia-phellodendron combination was associated with an 18% cortisol reduction and improved stress and mood scales.Combination-product supportive
Poivre M, Duez P. 2017Review of constituents, pharmacology, and safetyAcademic researchScope of clinical evidenceConcluded that very few magnolia clinical trials exist and human evidence largely depends on combinations.Supportive
§

Receipt — 3 References

All 3 cited sources were verified for existence at the original page (as of 2026-07-13).

Kalman DS, Feldman S, Feldman R, Schwartz HI, Krieger DR, Garrison R. Effect of a proprietary Magnolia and Phellodendron extract on stress levels in healthy women: a pilot, double-blind, placebo-controlled clinical trial. Nutr J. 2008;7:11. PMID: 18426577. DOI: 10.1186/1475-2891-7-11.
checked
Talbott SM, Talbott JA, Pugh M. Effect of Magnolia officinalis and Phellodendron amurense (Relora®) on cortisol and psychological mood state in moderately stressed subjects. J Int Soc Sports Nutr. 2013;10:37. PMID: 23924268. DOI: 10.1186/1550-2783-10-37.
checked
Poivre M, Duez P. Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents. J Zhejiang Univ Sci B. 2017;18(3):194-214. PMID: 28271656. DOI: 10.1631/jzus.B1600299.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-13 · Corrections: none

Cite this verdict

Magnolia bark extract (honokiol and magnolol) x improvement of anxiety, stress, and sleep Evidence Grade ? card
[Chamgap] Magnolia bark extract (honokiol and magnolol) x improvement of anxiety, stress, and sleep — Evidence Grade ?. 3 cited sources checked. Source: https://health-receipt.pages.dev/en/verdicts/sleep/magnolia-bark-anxiety-stress-sleep/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.